{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:37:29Z","timestamp":1790300249811,"version":"4.1.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,1,16]],"date-time":"2014-01-16T00:00:00Z","timestamp":1389830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s40618-013-0019-8","type":"journal-article","created":{"date-parts":[[2014,1,15]],"date-time":"2014-01-15T06:11:56Z","timestamp":1389766316000},"page":"99-112","source":"Crossref","is-referenced-by-count":37,"title":["Pituitary tumors and pregnancy: the interplay between a pathologic condition and a physiologic status"],"prefix":"10.1007","volume":"37","author":[{"given":"Rosario","family":"Pivonello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"De Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata S.","family":"Auriemma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Alviggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica F. S.","family":"Grasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Cozzolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"De Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"De Placido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Colao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,16]]},"reference":[{"key":"19_CR1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0025-6196(12)60946-X","volume":"65","author":"BW Scheithauer","year":"1990","unstructured":"Scheithauer BW, Sano T, Kovacs KT, Young WF Jr, Ryan N, Randall RV (1990) The pituitary gland in pregnancy. A clinicopathologic and immunohistochemical study of 69 cases. Mayo Clin Proc 65:461\u2013474","journal-title":"Mayo Clin Proc"},{"key":"19_CR2","unstructured":"Melmed S, Polonsky KS, Larsen PR, Kronenberg HM (eds) (2011) Williams textbook of endocrinology, 12th edn. Saunders Elsevier, Philadelphia"},{"key":"19_CR3","first-page":"S38","volume":"13","author":"ME Molitch","year":"2003","unstructured":"Molitch ME (2003) Pituitary tumors and pregnancy. GH IGF Res 13:S38\u2013S44","journal-title":"GH IGF Res"},{"issue":"3","key":"19_CR4","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cncr.20412","volume":"101","author":"S Ezzat","year":"2004","unstructured":"Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE (2004) The prevalence of pituitary adenomas: a systematic review. Cancer 101(3):613\u2013619","journal-title":"Cancer"},{"issue":"4","key":"19_CR5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1530\/EJE-07-0348","volume":"157","author":"A Beckers","year":"2007","unstructured":"Beckers A, Daly AF (2007) The clinical, pathological, and genetic features of familial isolated pituitary adenomas. Eur J Endocrinol 157(4):371\u2013382","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"19_CR6","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1227\/01.NEU.0000159647.64275.9D","volume":"56","author":"P Moertini","year":"2005","unstructured":"Moertini P, Losa M, Barzaghi R, Boari N, Giovanelli M (2005) Results of transsphenoidal surgery in a large series of patients with pituitary adenoma. Neurosurgery 56(6):1222\u20131233","journal-title":"Neurosurgery"},{"issue":"9 Suppl","key":"19_CR7","doi-asserted-by":"crossref","first-page":"s55","DOI":"10.1586\/14737140.6.9s.S55","volume":"6","author":"J Hirshfeld-Cytron","year":"2006","unstructured":"Hirshfeld-Cytron J, Kim HH (2006) Treatment of fertility in women with pituitary tumors. Expert Rev Anticancer Ther 6(9 Suppl):s55\u2013s62","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"19_CR8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1095\/biolreprod.103.027060","volume":"71","author":"V Chandrashekar","year":"2004","unstructured":"Chandrashekar V, Zaczek D, Bartke A (2004) The consequences of altered somatotropic system on reproduction. Biol Reprod 71(1):17\u201327","journal-title":"Biol Reprod"},{"key":"19_CR9","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/oxfordjournals.humrep.a136095","volume":"10","author":"J Levy","year":"1995","unstructured":"Levy J (1995) Endogenous plasma GH and the occurrence of pregnancies in patients undergoing in vitro fertilization and embryo transfer with ovarian stimulation. Human Reprod 10:1065\u20131069","journal-title":"Human Reprod"},{"issue":"3","key":"19_CR10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/0003-4819-129-3-199808010-00012","volume":"129","author":"GP Chrousos","year":"1998","unstructured":"Chrousos GP, Torpy DJ, Gold PW (1998) Interactions between the hypothalamic\u2013pituitary\u2013adrenal axis and the female reproductive system: clinical implications. Ann Int Med 129(3):229\u2013240","journal-title":"Ann Int Med"},{"key":"19_CR11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.taap.2003.09.016","volume":"194","author":"PS Cooke","year":"2004","unstructured":"Cooke PS, Holsberger DR, Witorsch RJ, Sylvester PW, Meredith JM, Treinen KA, Chapin RE (2004) Thyroid hormone, glucocorticoids, and prolactin at the nexus of physiology, reproduction, and toxicology. Toxicol Appl Pharmacol 194:309\u2013335","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"19_CR12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2265.2007.02752.x","volume":"66","author":"K Poppe","year":"2007","unstructured":"Poppe K, Velkeniers B, Glinoer D (2007) Thyroid disease and female reproduction. Clin Endocrinol (Oxf) 66(3):309\u2013321","journal-title":"Clin Endocrinol (Oxf)"},{"key":"19_CR13","first-page":"64","volume":"39","author":"H Dinc","year":"1998","unstructured":"Dinc H, Esen F, Demirci A, Sari A, Resit Gumele H (1998) Pituitary dimensions and volume measurements in pregnancy and post partum. MR assessment. Acta Radiol 39:64\u201369","journal-title":"Acta Radiol"},{"key":"19_CR14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1148\/radiology.181.2.1924800","volume":"181","author":"AD Elster","year":"1991","unstructured":"Elster AD, Sanders TG, Vines FS, Chen MY (1991) Size and shape of the pituitary gland during pregnancy and post partum: measurement with MR imaging. Radiology 181:531\u2013535","journal-title":"Radiology"},{"key":"19_CR15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0002-9343(88)80346-2","volume":"85","author":"JG Gonzalez","year":"1988","unstructured":"Gonzalez JG, Elizondo G, Saldivar D, Nanez H, Todd LE, Villarreal JZ (1988) Pituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging. Am J Med 85:217\u2013220","journal-title":"Am J Med"},{"key":"19_CR16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1096-6374(02)00018-7","volume":"12","author":"MJ Waters","year":"2002","unstructured":"Waters MJ, Kaye PL (2002) The role of growth hormone in fetal development. Growth Hormon IGF Res 12:137\u2013146","journal-title":"Growth Hormon IGF Res"},{"key":"19_CR17","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1210\/jcem-66-6-1171","volume":"66","author":"F Frankenne","year":"1988","unstructured":"Frankenne F, Closset J, Gomez F, Scippo ML, Smal J, Hennen G (1988) The physiology of growth hormones (GHs) in pregnant women and partial characterization of the placental GH variant. J Clin Endocrinol Metab 66:1171\u20131180","journal-title":"J Clin Endocrinol Metab"},{"key":"19_CR18","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1471-0528.1989.tb03352.x","volume":"106","author":"L Eriksson","year":"1989","unstructured":"Eriksson L, Frankenne F, Eden S, Hennen G, Von Schoultz B (1989) Growth hormone 24-h serum profiles during pregnancy lack of pulsatility for the secretion of the placental variant. Br J Obstet Gynaecol 106:949\u2013953","journal-title":"Br J Obstet Gynaecol"},{"key":"19_CR19","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1210\/jcem-71-3-725","volume":"71","author":"A Beckers","year":"1990","unstructured":"Beckers A, Stevenaert A, Foidart J-M, Hennen G, Frankenne F (1990) Placental and pituitary growth hormone secretion during pregnancy in acromegalic women. J Clin Endocrinol Metab 71:725\u2013731","journal-title":"J Clin Endocrinol Metab"},{"key":"19_CR20","first-page":"2447","volume-title":"Maternal\u2013fetal endocrinology","author":"JSD Winter","year":"1998","unstructured":"Winter JSD (1998) Fetal and neonatal adrenocortical physiology. In: Polin RA, Fox WW (eds) Maternal\u2013fetal endocrinology. WB Saunders, Philadelphia, pp 2447\u20132459"},{"key":"19_CR21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1071\/RD9940141","volume":"6","author":"GC Liggins","year":"1994","unstructured":"Liggins GC (1994) The role of cortisol in preparing the fetus for birth. Reprod Fertil Dev 6:141\u2013150","journal-title":"Reprod Fertil Dev"},{"key":"19_CR22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1210\/edrv-11-1-151","volume":"11","author":"GJ Pepe","year":"1990","unstructured":"Pepe GJ, Albrecht ED (1990) Regulation of the primate fetal adrenal cortex. Endocr Rev 11:151\u2013176","journal-title":"Endocr Rev"},{"key":"19_CR23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1196\/annals.1290.016","volume":"997","author":"G Mastorakos","year":"2003","unstructured":"Mastorakos G, Ilias I (2003) Maternal and fetal hypothalamic\u2013pituitary\u2013adrenal axes during pregnancy and postpartum. Ann N Y Acad Sci 997:136\u2013149","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"19_CR24","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1210\/er.2004-0025","volume":"26","author":"JR Lindsay","year":"2005","unstructured":"Lindsay JR, Nieman LK (2005) The hypothalamic\u2013pituitary\u2013adrenal axis in pregnancy: challenges in disease detection and treatment. Endocr Rev 26(6):775\u2013799","journal-title":"Endocr Rev"},{"issue":"5","key":"19_CR25","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1210\/jc.2004-2361","volume":"90","author":"JR Lindsay","year":"2005","unstructured":"Lindsay JR, Jonklaas J, Oldfield EH, Nieman LK (2005) Cushing\u2019s syndrome during pregnancy: personal experience and review of the literature. J Clin Endocrinol Metab 90(5):3077\u20133083","journal-title":"J Clin Endocrinol Metab"},{"key":"19_CR26","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1210\/jcem-51-3-466","volume":"51","author":"WE Nolten","year":"1980","unstructured":"Nolten WE, Lindheimer MD, Rueckert PA, Oparil S, Ehrlich EN (1980) Diurnal patterns and regulation of cortisol secretion in pregnancy. J Clin Endocrinol Metab 51:466\u2013472","journal-title":"J Clin Endocrinol Metab"},{"key":"19_CR27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/thy.2000.10.229","volume":"10","author":"DA Fisher","year":"2000","unstructured":"Fisher DA, Nelson JC, Carlton EI, Wilcox RB (2000) Maturation of human hypothalamic\u2013pituitary\u2013thyroid function and control. Thyroid 10:229\u2013234","journal-title":"Thyroid"},{"key":"19_CR28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM198907063210103","volume":"321","author":"T Vulsma","year":"1989","unstructured":"Vulsma T, Gons MH, de Vijlder JJ (1989) Maternal\u2013fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med 321:13\u201316","journal-title":"N Engl J Med"},{"issue":"2","key":"19_CR29","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1210\/jcem-71-2-276","volume":"71","author":"D Glinoer","year":"1990","unstructured":"Glinoer D, de Nayer P, Bourdoux P, Lemone M, Robyn C, van Steirteghem A, Kinthaert J, Lejeune B (1990) Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab 71(2):276\u2013287","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"19_CR30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.ftd.0000194498.32398.7b","volume":"28","author":"OP Soldin","year":"2006","unstructured":"Soldin OP (2006) Thyroid function testing in pregnancy and thyroid disease: trimester-specific reference intervals. Ther Drug Monit 28(1):8\u201311","journal-title":"Ther Drug Monit"},{"key":"19_CR31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0002-9378(81)90006-5","volume":"139","author":"JV Kredentser","year":"1981","unstructured":"Kredentser JV, Hoskins CF, Scott JZ (1981) Hyperprolactinemia: a significant factor in female infertility. Am J Obstet Gynecol 139:264\u2013267","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"19_CR32","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/er.2005-9998","volume":"27","author":"MP Gillam","year":"2006","unstructured":"Gillam MP, Molitch ME, Lombardi G, Colao A (2006) Advances in the treatment of prolactinomas. Endocr Rev 27(5):485\u2013534","journal-title":"Endocr Rev"},{"key":"19_CR33","first-page":"117","volume":"44","author":"ME Molitch","year":"1999","unstructured":"Molitch ME (1999) Diagnosis and treatment of prolactinomas. Adv Intern Med 44:117\u2013153","journal-title":"Adv Intern Med"},{"key":"19_CR34","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM199410063311403","volume":"331","author":"J Webster","year":"1994","unstructured":"Webster J, Piscitelli G, Polli A, Ferrari CI, Ismail I, Scanlon MF, The Cabergoline Comparative Study Group (1994) A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. N Engl J Med 331:904\u2013909","journal-title":"N Engl J Med"},{"issue":"2","key":"19_CR35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2265.2006.02562.x","volume":"65","author":"FF Casanueva","year":"2006","unstructured":"Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD, Brue T, Cappabianca P, Colao A, Fahlbusch R, Fideleff H, Hadani M, Kelly P, Kleinberg D, Laws E, Marek J, Scanlon M, Sobrinho LG, Wass JA, Giustina A (2006) Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol 65(2):265\u2013273","journal-title":"Clin Endocrinol"},{"key":"19_CR36","first-page":"727","volume":"83","author":"V Herman-Bonert","year":"1998","unstructured":"Herman-Bonert V, Seliverstow M, Melmed S (1998) Pregnancy in acromegaly: successful therapeutic outcome. J Clin Endocrinol Metab 83:727\u2013731","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"19_CR37","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1530\/eje.1.02215","volume":"155","author":"R Cozzi","year":"2006","unstructured":"Cozzi R, Attanasio R, Barausse M (2006) Pregnancy in acromegaly: a one-center experience. Eur J Endocrinol 155(2):279\u2013284","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"19_CR38","first-page":"13","volume":"35","author":"LFS Grasso","year":"2010","unstructured":"Grasso LFS, Pivonello R, Auriemma RS, Galdiero M, De Leo M, Cozzolino A, Vitale P, Simeoli C, Lombardi G, Colao A (2010) Acromegaly and women fertility. Minerva Endocrinol 35(4):13\u201326","journal-title":"Minerva Endocrinol"},{"key":"19_CR39","first-page":"130","volume":"79","author":"MA Beuscher","year":"1992","unstructured":"Beuscher MA, McClamrock HD, Adashi EY (1992) Cushing\u2019s syndrome in pregnancy. Obstet Gynecol 79:130\u2013137","journal-title":"Obstet Gynecol"},{"issue":"1","key":"19_CR40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2265.1980.tb03127.x","volume":"12","author":"R Benoit","year":"1980","unstructured":"Benoit R, Pearson-Murphy BE, Robert F, Marcovitz S, Hardy J, Tsoukas G, Gardiner RJ (1980) Hyperthyroidism due to a pituitary TSH secreting tumour with amenorrhoea-galactorrhoea. Clin Endocrinol 12(1):11\u201319","journal-title":"Clin Endocrinol"},{"key":"19_CR41","doi-asserted-by":"crossref","first-page":"473","DOI":"10.7326\/0003-4819-121-7-199410010-00001","volume":"121","author":"MJ Kupersmith","year":"1994","unstructured":"Kupersmith MJ, Rosenberg C, Kleinberg D (1994) Visual loss in pregnant women with pituitary adenomas. Ann Intern Med 121:473\u2013477","journal-title":"Ann Intern Med"},{"key":"19_CR42","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/S0140-6736(98)03356-X","volume":"352","author":"A Colao","year":"1998","unstructured":"Colao A, Lombardi G (1998) Growth-hormone and prolactin excess. Lancet 352:1455\u20131461","journal-title":"Lancet"},{"key":"19_CR43","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1210\/jcem.82.11.4368","volume":"82","author":"A Colao","year":"1997","unstructured":"Colao A, Di Sarno A, Landi ML, Cirillo S, Sarnacchiaro F, Facciolli G, Pivonello R, Cataldi M, Merola B, Annunziato L, Lombardi G (1997) Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage. J Clin Endocrinol Metab 82:3574\u20133579","journal-title":"J Clin Endocrinol Metab"},{"key":"19_CR44","first-page":"2247","volume":"85","author":"A Colao","year":"2000","unstructured":"Colao A, Di Sarno A, Landi ML, Scavuzzo F, Cappabianca P, Pivonello R, Volpe R, Di Salle F, Cirillo S, Annunziato L, Lombardi G (2000) Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients. J Clin Endocrinol Metab 85:2247\u20132252","journal-title":"J Clin Endocrinol Metab"},{"key":"19_CR45","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1210\/jcem.86.11.8054","volume":"86","author":"A Sarno Di","year":"2001","unstructured":"Di Sarno A, Landi ML, Cappabianca P, Di Salle F, Rossi FW, Pivonello R, Di Somma C, Faggiano A, Lombardi G, Colao A (2001) Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy. J Clin Endocrinol Metab 86:5256\u20135261","journal-title":"J Clin Endocrinol Metab"},{"key":"19_CR46","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2265.2000.01016.x","volume":"53","author":"A Sarno Di","year":"2000","unstructured":"Di Sarno A, Landi ML, Marzullo P, Di Somma C, Pivonello R, Cerbone G, Lombardi G, Colao A (2000) The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas. Clin Endocrinol 53:53\u201360","journal-title":"Clin Endocrinol"},{"key":"19_CR47","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/14656566.1.3.555","volume":"1","author":"A Colao","year":"2000","unstructured":"Colao A, Lombardi G, Annunziato L (2000) Cabergoline. Expert Opin Pharmacother 1:555\u2013574","journal-title":"Expert Opin Pharmacother"},{"key":"19_CR48","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1056\/NEJM198505233122106","volume":"312","author":"ME Molitch","year":"1985","unstructured":"Molitch ME (1985) Pregnancy and the hyperprolactinemic woman. N Engl J Med 312:1364\u20131370","journal-title":"N Engl J Med"},{"key":"19_CR49","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-1-4615-1435-0_4","volume-title":"Pituitary tumors and pregnancy","author":"NR Musolino","year":"2001","unstructured":"Musolino NR, Bronstein MD (2001) Prolactinomas and pregnancy. In: Bronstein MD (ed) Pituitary tumors and pregnancy. Kluwer Academic Publishers, Norwell, pp 91\u2013108"},{"key":"19_CR50","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1210\/jc.2012-3039","volume":"98","author":"RS Auriemma","year":"2013","unstructured":"Auriemma RS, Perone Y, Di Sarno A, Grasso LFS, Guerra E, Gasperi M, Pivonello R, Colao A (2013) Results of a single-center observational 10-year survey study on recurrence of hyperprolactinemia after pregnancy and lactation. J Clin Endocrinol Metab 98:372\u2013379","journal-title":"J Clin Endocrinol Metab"},{"key":"19_CR51","unstructured":"Krupp P, Monka C, Richter K (1988) The safety aspects of infertility treatments. In: Proceedings of the second world congress of gynecology and obstetrics, Rio de Janeiro, p 9"},{"issue":"8","key":"19_CR52","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0002-9378(83)90968-7","volume":"146","author":"P Konopka","year":"1983","unstructured":"Konopka P, Raymond JP, Merceron RE, Seneze J (1983) Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas. Am J Obstet Gynecol 146(8):935\u2013938","journal-title":"Am J Obstet Gynecol"},{"key":"19_CR53","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1210\/jcem.84.7.5810","volume":"84","author":"J Verhelst","year":"1999","unstructured":"Verhelst J, Abs R, Maiter D, van den Bruel A, Vandeweghe M, Velkeniers B, Mockel J, Lamberigts G, Petrossians P, Coremans P, Mahler C, Stevenaert A, Verlooy J, Raftopoulos C, Beckers A (1999) Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. J Clin Endocrinol Metab 84:2518\u20132522","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"19_CR54","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2265.2007.03000.x","volume":"68","author":"A Colao","year":"2008","unstructured":"Colao A, Abs R, B\u00e1rcena DG, Chanson P, Paulus W, Kleinberg DL (2008) Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study. Clin Endocrinol (Oxf) 68(1):66\u201371 Epub 2007 Aug 29","journal-title":"Clin Endocrinol (Oxf)"},{"key":"19_CR55","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0890-6238(02)00055-2","volume":"16","author":"E Ricci","year":"2002","unstructured":"Ricci E, Parazzini F, Motta T, Ferrari CI, Colao A, Clavenna A, Rocchi F, Gangi E, Paracchi S, Gasperi M, Lavezzari M, Nicolosi AE, Ferrero S, Landi ML, Beck-Peccoz P, Bonati M (2002) Pregnancy outcome after cabergoline treatment in early weeks of gestation. Reprod Toxicol 16:791\u2013793","journal-title":"Reprod Toxicol"},{"key":"19_CR56","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0890-6238(96)00063-9","volume":"10","author":"E Robert","year":"1996","unstructured":"Robert E, Musatti L, Piscitelli G, Ferrari CI (1996) Pregnancy outcome after treatment with the ergot derivative, cabergoline. Reprod Toxicol 10:333\u2013337","journal-title":"Reprod Toxicol"},{"issue":"6","key":"19_CR57","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.beem.2011.05.011","volume":"25","author":"ME Molitch","year":"2011","unstructured":"Molitch ME (2011) Prolactinoma in pregnancy. Best Pract Res Clin Endocrinol Metab 25(6):885\u2013889","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"19_CR58","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1210\/jc.2009-2605","volume":"95","author":"M Ono","year":"2010","unstructured":"Ono M, Miki N, Amano K, Kawamata T, Seki T, Makino R, Takano K, Izumi S, Okada Y, Hori T (2010) Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas. J Clin Endocrinol Metab 95(6):2672\u20132679","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"19_CR59","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2265.2010.03808.x","volume":"73","author":"M Lebbe","year":"2010","unstructured":"Lebbe M, Hubinont C, Bernard P, Maiter D (2010) Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women. Clin Endocrinol (Oxf) 73(2):236\u2013242","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"19_CR60","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11102-010-0243-6","volume":"13","author":"G Stalldecker","year":"2010","unstructured":"Stalldecker G, Mallea-Gil MS, Guitelman M, Alfieri A, Ballarino MC, Boero L, Chervin A, Danilowicz K, Diez S, Fainstein-Day P, Garc\u00eda-Basavilbaso N, Glerean M, Gollan V, Katz D, Loto MG, Manavela M, Rogozinski AS, Servidio M, Vitale NM (2010) Effects of cabergoline on pregnancy and embryo-fetal development: retrospective study on 103 pregnancies and a review of the literature. Pituitary 13(4):345\u2013350","journal-title":"Pituitary"},{"key":"19_CR61","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/mds.10040","volume":"17","author":"M Mari De","year":"2002","unstructured":"De Mari M, Zenzola A, Lamberti P (2002) Antiparkinsonian treatment in pregnancy. Mov Disord 17:428\u2013429","journal-title":"Mov Disord"},{"key":"19_CR62","volume-title":"Review of pregnancy reports in patients on pergolide treatment","author":"V Acharya","year":"2004","unstructured":"Acharya V (2004) Review of pregnancy reports in patients on pergolide treatment. Eli Lilly Co., Indianapolis"},{"issue":"4","key":"19_CR63","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2165\/00002018-199614040-00003","volume":"14","author":"J Webster","year":"1996","unstructured":"Webster J (1996) A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation. Drug Saf 14(4):228\u2013238","journal-title":"Drug Saf"},{"key":"19_CR64","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0002-9378(16)32785-5","volume":"138","author":"JB Brodsky","year":"1980","unstructured":"Brodsky JB, Cohen EN, Brown BW Jr, Wu ML, Whitcher C (1980) Surgery during pregnancy and fetal outcome. Am J Obstet Gynecol 138:1165\u20131167","journal-title":"Am J Obstet Gynecol"},{"key":"19_CR65","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0301-2115(95)02257-0","volume":"63","author":"AM Rossi","year":"1995","unstructured":"Rossi AM, Vilska S, Heinonen PK (1995) Outcome of pregnancies in women with treated or untreated hyperprolactinemia. Eur J Obstet Gynecol Reprod Biol 63:143\u2013146","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"8","key":"19_CR66","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/oxfordjournals.humrep.a137010","volume":"4","author":"PG Crosignani","year":"1989","unstructured":"Crosignani PG, Mattei AM, Scarduelli C, Cavioni V, Boracchi P (1989) Is pregnancy the best treatment for hyperprolactinemia? Hum Reprod 4(8):910\u2013912","journal-title":"Hum Reprod"},{"issue":"5","key":"19_CR67","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0015-0282(16)59182-1","volume":"47","author":"H Ikegami","year":"1987","unstructured":"Ikegami H, Aono T, Koizumi K, Koike K, Fukui H, Tanizawa O (1987) Relationship between the methods of treatment for prolactinomas and the puerperal lactation. Fertil Steril 47(5):867\u2013869","journal-title":"Fertil Steril"},{"key":"19_CR68","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ecl.2005.09.011","volume":"35","author":"ME Molitch","year":"2006","unstructured":"Molitch ME (2006) Pituitary disorders during pregnancy. Endocrinol Metab Clin North Am 35:99\u2013116","journal-title":"Endocrinol Metab Clin North Am"},{"key":"19_CR69","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/er.2002-0022","volume":"25","author":"A Colao","year":"2004","unstructured":"Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25:102\u2013152","journal-title":"Endocr Rev"},{"key":"19_CR70","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1056\/NEJM199004053221405","volume":"322","author":"S Melmed","year":"1990","unstructured":"Melmed S (1990) Acromegaly. N Engl J Med 322:966\u2013977","journal-title":"N Engl J Med"},{"key":"19_CR71","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/S0140-6736(01)06844-1","volume":"358","author":"AJ Lely van der","year":"2001","unstructured":"van der Lely AJ, Hutson RK, Trainer PJ, Besser GM, Barkan AL, Katznelson L, Klibanski A, Herman-Bonert V, Melmed S, Vance ML, Freda PU, Stewart PM, Friend KE, Clemmons DR, Johannsson G, Stavrou S, Cook DM, Phillips LS, Strasburger CJ, Hackett S, Zib KA, Davis RJ, Scarlett JA, Thorner MO (2001) Long term treatment of acromegaly with pegvisomant, a growth hormone antagonist. Lancet 358:1754\u20131759","journal-title":"Lancet"},{"issue":"3","key":"19_CR72","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1530\/eje.1.02112","volume":"154","author":"A Colao","year":"2006","unstructured":"Colao A, Pivonello R, Auriemma RS, De Martino MC, Bidlingmaier M, Briganti F, Tortora F, Burman P, Kourides IA, Strasburger CJ, Lombardi G (2006) Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance. Eur J Endocrinol 154(3):467\u2013477","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"19_CR73","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-2005-873004","volume":"114","author":"A Atmaca","year":"2006","unstructured":"Atmaca A, Dagdelen S, Erbas T (2006) Follow-up of pregnancy in acromegalic women: different presentations and outcomes. Exp Clin Endocrinol Diabetes 114(3):135\u2013139","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"19_CR74","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1210\/jcem.82.2.3648","volume":"82","author":"A Colao","year":"1997","unstructured":"Colao A, Ferone D, Marzullo P, Di Sarno A, Cerbone G, Sarnacchiaro F, Cirillo S, Merola B, Lombardi G (1997) Effect of different dopaminergic agents in the treatment of acromegaly. J Clin Endocrinol Metab 82:518\u2013523","journal-title":"J Clin Endocrinol Metab"},{"key":"19_CR75","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1365-2265.2002.01549.x","volume":"57","author":"G Blackhurst","year":"2002","unstructured":"Blackhurst G, Strachan MW, Collie D, Gregor A, Statham PF, Seckl JE (2002) The treatment of a thyrotropin-secreting pituitary macroadenoma with octreotide in twin pregnancy. Clin Endocrinol (Oxf) 57:401\u2013404","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"19_CR76","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/BF03345293","volume":"27","author":"C Boulanger","year":"2004","unstructured":"Boulanger C, Vezzosi D, Bennet A, Lorenzini F, Fauvel J, Caron P (2004) Normal pregnancy in a woman with nesidioblastosis treated with somatostatin analog octreotide. J Endocrinol Invest 27(5):465\u2013470","journal-title":"J Endocrinol Invest"},{"key":"19_CR77","first-page":"1164","volume":"81","author":"P Caron","year":"1996","unstructured":"Caron P, Gerbeau C, Pradayrol L, Simonetta C, Bayard F (1996) Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with somatostatin analog (octreotide). J Clin Endocrinol Metab 81:1164\u20131168","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"19_CR78","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1210\/jc.2007-0997","volume":"92","author":"SR Brian","year":"2007","unstructured":"Brian SR, Bidlingmaier M, Wajnrajch MP, Weinzimer SA, Inzucchi SE (2007) Treatment of acromegaly with pegvisomant during pregnancy: maternal and fetal effects. J Clin Endocrinol Metab 92(9):3374\u20133377","journal-title":"J Clin Endocrinol Metab"},{"key":"19_CR79","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11102-011-0330-3","volume":"15","author":"V Cheng","year":"2012","unstructured":"Cheng V, Faiman C, Kennedy L, Khoury F, Hatipoglu B, Weil R, Hamrahian A (2012) Pregnancy and acromegaly: a review. Pituitary 15:59\u201363","journal-title":"Pituitary"},{"issue":"4","key":"19_CR80","first-page":"49","volume":"35","author":"P Maffei","year":"2010","unstructured":"Maffei P, Tamagno G, Nardelli GB, Milan G, Martini C, DeCarlo E, Dassie F, Vettor R, Sicolo N (2010) Treatment with somatostatin analogs in acromegalic women during pregnancy. Minerva Endocrinol 35(4):49\u201369","journal-title":"Minerva Endocrinol"},{"key":"19_CR81","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1210\/jc.2009-2331","volume":"95","author":"P Caron","year":"2010","unstructured":"Caron P, Broussaud S, Bertherat J, Borson-Chazot F, Brue T, Cortet-Rudelli C, Chanson P (2010) Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women. J Clin Endocrinol Metab 95:4680\u20134687","journal-title":"J Clin Endocrinol Metab"},{"key":"19_CR82","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1365-2265.2011.04180.x","volume":"76","author":"S Cheng","year":"2012","unstructured":"Cheng S, Grasso LFS, Martinez-Orozco JA, Al-Agha R, Pivoenllo R, Colao A, Ezzat S (2012) Pregnancy in acromegaly: experience from two referral centers and systematic review of literature. Clin Endocrinol 76:264\u2013271","journal-title":"Clin Endocrinol"},{"key":"19_CR83","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s11102-012-0420-x","volume":"16","author":"S Melmed","year":"2013","unstructured":"Melmed S, Casanueva FF, Klibanski A, Bronstein MD, Chanson P, Lamberts SW, Strasburger CJ, Wass JAH, Giustina A (2013) A consensus on the diagnosis and treatment of acromegaly complications. Pituitary 16:294\u2013302","journal-title":"Pituitary"},{"issue":"2","key":"19_CR84","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2265.1987.tb01148.x","volume":"27","author":"JS Bevan","year":"1987","unstructured":"Bevan JS, Gough MH, Gillmer MD, Burke CW (1987) Cushing\u2019s syndrome in pregnancy: the timing of definitive treatment. Clin Endocrinol 27(2):225\u2013233","journal-title":"Clin Endocrinol"},{"key":"19_CR85","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0002-9378(90)90859-6","volume":"162","author":"DC Aron","year":"1990","unstructured":"Aron DC, Schnall AM, Sheeler LR (1990) Cushing\u2019s syndrome and pregnancy. Am J Obstet Gynecol 162:244\u2013252","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"19_CR86","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ecl.2007.10.010","volume":"37","author":"R Pivonello","year":"2008","unstructured":"Pivonello R, De Martino MC, De Leo M, Lombardi G, Colao A (2008) Cushing\u2019s syndrome. Endocrinol Metab Clin North Am 37(1):135\u2013149","journal-title":"Endocrinol Metab Clin North Am"},{"key":"19_CR87","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0301-2115(95)02258-9","volume":"64","author":"A Chico","year":"1996","unstructured":"Chico A, Manzanares JM, Halperin I, Martonez de Osaba MJ, Adelantado J, Webb SM (1996) Cushing\u2019s disease and pregnancy. Eur J Obstet Gynecol Reprod Biol 64:143\u2013146","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"19_CR88","first-page":"83","volume":"1","author":"B Guilhaume","year":"1992","unstructured":"Guilhaume B, Sanson ML, Billaud L, Bertagna X, Laudat MH, Luton JP (1992) Cushing\u2019s syndrome and pregnancy: aetiologies and prognosis in twenty-two patients. Eur J Med 1(2):83\u201389","journal-title":"Eur J Med"},{"issue":"6","key":"19_CR89","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.beem.2011.08.004","volume":"25","author":"O Lekarev","year":"2011","unstructured":"Lekarev O, New MI (2011) Adrenal disease in pregnancy. Best Pract Res Clin Endocrinol Metab 25(6):959\u2013973","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"19_CR90","first-page":"610","volume":"17","author":"P Beck-Peccoz","year":"1996","unstructured":"Beck-Peccoz P, Brucker-Davis F, Persani L, Smallridge RC, Weintraub BD (1996) Thyrotropin-secreting pituitary tumors. Endocr Rev 17(6):610\u2013638","journal-title":"Endocr Rev"},{"issue":"2","key":"19_CR91","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1210\/jcem.84.2.5505","volume":"84","author":"F Brucker-Davis","year":"1999","unstructured":"Brucker-Davis F, Oldfield EH, Skarulis MC, Doppman JL, Weintraub BD (1999) Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab 84(2):476\u2013486","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"19_CR92","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1023\/B:PITU.0000004802.47010.00","volume":"6","author":"S Chaiamnuay","year":"2003","unstructured":"Chaiamnuay S, Moster M, Katz MR, Kim YN (2003) Successful management of a pregnant woman with a TSH secreting pituitary adenoma with surgical and medical therapy. Pituitary 6(2):109\u2013113","journal-title":"Pituitary"},{"issue":"5","key":"19_CR93","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1210\/jc.2002-021820","volume":"88","author":"Y Murata","year":"2003","unstructured":"Murata Y, Ando H, Nagasaka T, Takahashi I, Saito K, Fukugaki H, Matsuzawa K, Mizutani S (2003) Successful pregnancy after bromocriptine therapy in an anovulatory woman complicated with ovarian hyperstimulation caused by follicle-stimulating hormone-producing plurihormonal pituitary microadenoma. J Clin Endocrinol Metab 88(5):1988\u20131993","journal-title":"J Clin Endocrinol Metab"},{"key":"19_CR94","doi-asserted-by":"crossref","unstructured":"Sedgh G et al (2012) Induced abortion: incidence and trends worldwide from 1995 to 2008. Lancet. doi: 10.1016\/S0140-6736(11)61786-8","DOI":"10.1016\/S0140-6736(11)61786-8"}],"updated-by":[{"DOI":"10.1007\/s40618-014-0072-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000}}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-013-0019-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-013-0019-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-013-0019-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:09:19Z","timestamp":1716422959000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-013-0019-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,16]]},"references-count":94,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["19"],"URL":"https:\/\/doi.org\/10.1007\/s40618-013-0019-8","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,16]]}}}